Medplus Health Services Ltd

NSE: MEDPLUS · BSE: 543427 · Healthcare · 93 announcements

Share price: ₹646.80
Market cap: ₹7,770 Cr
Revenue (annual): ₹6,892 Cr
Net profit (annual): ₹219.7 Cr
P/E (TTM): 36.9×Sector 53.1×
Promoter holding: 40.19%-0.03% QoQ
FII holding: 14.38%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 6 Adverse Business Impact 4 Board Meeting Outcome 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

25 Sep 2026 19:09 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus Health Services' subsidiary, Optival Health Solutions, faced a three-day drug license suspension at a store by the Drugs Control Administration, impacting operations by ₹0.01 Crore.

Value: ₹0.01 Cr
From: Drugs Control Administration, Haveri Circle, Karnataka

Read the filing ↗

16 Sep 2026 17:20 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus Health Services reported a 7-day drug license suspension for a subsidiary store, impacting its operations with an estimated financial loss of ₹0.02 Crore.

Value: ₹0.02 Cr
Execution: 7 days

Read the filing ↗

12 Sep 2026 13:56 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus Health Services' subsidiary, Optival Health Solutions, faced drug license suspensions for two stores from regulatory authorities, causing a total financial impact of Rs 0.0961 Crore.

Value: ₹0.10 Cr
Execution: 5 to 15 days

Read the filing ↗

10 Sep 2026 17:07 IST BSE

Adverse Business Impact

Medplus Health Services Adverse Business Impact

Medplus Health Services' subsidiary, Optival Health Solutions, faced a five-day drug license suspension at its Kapikad store due to regulatory violations. The impact is Rs 0.03 Crore.

Value: ₹0.03 Cr
suspension period: 5.0 days

Read the filing ↗